New Vernon Capital Holdings Ii LLC Dr Reddys Laboratories LTD Transaction History

New Vernon Capital Holdings Ii LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$57.98 - $73.08 $6.73 Million - $8.49 Million	-116,158 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $1.72 Million - $1.96 Million	-27,511 Reduced 19.15%	116,158 $8.28 Million
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $943,982 - $1.33 Million	18,369 Added 14.66%	143,669 $9.99 Million
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $733,059 - $1.01 Million	18,535 Added 17.36%	125,300 $6.64 Million
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $1.66 Million - $2.19 Million	47,663 Added 80.65%	106,765 $4.31 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $244,130 - $289,570	-6,772 Reduced 10.28%	59,102 $2.22 Million
Q1 2019 May 13, 2019	BUY	$35.77 - $40.57 $458,714 - $520,269	12,824 Added 24.17%	65,874 $2.67 Million
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $1.69 Million - $2.04 Million	53,050 New	53,050 $2 Million
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $1.92 Million - $2.36 Million	-67,305 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$34.15 - $37.62 $2.3 Million - $2.53 Million	67,305	67,305 $2.53 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.4B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.